Following binding of its ligand, the EGFR complex undergoes dimerization and internalization (Kim et al.,

2001, Puri et al., 2005 and Wilde et al., 1999). Lipid rafts have the ability to assemble the molecular machineries necessary for intracellular propagation of EGFR effector signals (Puri et al., 2005). EGFR signaling occurs within lipid rafts (Maxfield, 2002 and Simons and Toomre, 2000), whereas its endocytosis PLX3397 solubility dmso occurs mostly through the clathrin-coated pits (Conner and Schmid, 2003, Puri et al., 2005 and Wilde et al., 1999). Lipid rafts propagate survival signals via EGFR ( Pike and Casey, 2002). The n-3 polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), decrease proliferation and induce apoptosis in MDA-MB-231 human breast cancer cells. Schley et al. (2007) have examined the effects of EPA and DHA on the lipid composition of lipid rafts, as well as raft localization and phosphorylation of EGFR. Treatment with EPA and DHA was found to decrease lipid raft sphingomyelin, cholesterol, and diacylglycerol content in the raft, whereas the ceramide levels were increased. Interestingly, these changes were associated with a marked decrease in the EGFR level in these microdomains, along with increases in the phosphorylation of both EGFR and p38 MAPK. In another hand, sustained activation of EGFR induced by aplidin has been linked to apoptosis in human

breast cancer selleck inhibitor cells ( Cuadrado et al., 2003), it is thus tempting to speculate that EPA and DHA may decrease the growth of breast tumors by acting on the EGFR signaling via membrane rafts. If so, the remodeling of lipid rafts by exogenous fatty acids or chemicals could be a therapeutic for treating breast and possibly

other cancers. Activation of apoptosis is often modified by signaling through protein kinase cascades which arise from the cell surface. The kinase cascade can change substrate conformation or interactions as well as alter gene expressions. Lipid rafts play a role in the activation process of the receptor tyrosine kinases by allowing cross-linking and aggregation of the receptors (Nakashima et al., 2002 and Rhee et Tolmetin al., 2005). A major pathway that lies downstream of the membrane associated receptor tyrosine kinases is activation of Raf-1/Ras by lipid raft (Simons and Toomre, 2000 and Zhong et al., 2001), which is followed by phosphorylation-mediated activation of MAP kinases which then phosphorylate and activate ERK1/2, JNK1/2/3 and p38α/β/γ pathways in mammalian cells (Ho et al., 2002, Khan et al., 2006, Lu et al., 2007, Misra et al., 2007 and Zhong et al., 2001). Raf-1 is a component of lipid rafts, and because the deregulated over-expression of MAPK pathway is frequently seen in a variety of cell deaths, modulation of MAPK by disruption of lipid rafts may be an important determinant in chemically-induced cell death.